| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 07/22/2008 | US7402569 Combining such as sulforaphane with glucosinolate component; economical food additive or dietary supplement |
| 07/22/2008 | US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/22/2008 | US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine) |
| 07/22/2008 | US7402410 Humanized immunoglobulin reactive with α4β7 integrin |
| 07/22/2008 | US7402324 Process for preparing aqueous extracts of plants and extracts so obtained |
| 07/22/2008 | US7402321 Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles |
| 07/22/2008 | US7402305 Comprises nucleotide sequences coding protein with antiproliferative and viricidal activity for use in treatment and prevention of cancer, nervous system, bone and autoimmune disorders |
| 07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/22/2008 | CA2333205C A beneficial microbe composition, new protective materials for the microbes, the method to prepare and uses thereof |
| 07/22/2008 | CA2283830C Composition for forming solid particles |
| 07/17/2008 | WO2008085229A2 Cell-based therapies for treating liver disease |
| 07/17/2008 | WO2008084864A1 Capsaicin receptor activator and apparatus for spraying the same |
| 07/17/2008 | WO2008084561A1 HELICOBACTER PYLORI GROWTH INHIBITOR CONTAINING α-N-ACETYLGLUCOSAMINYL-BINDING MONOSACCHARIDE DERIVATIVE |
| 07/17/2008 | WO2008084253A1 Use of a galactolipid for wound and ulcer healing |
| 07/17/2008 | WO2008083561A1 Oral pharmaceutical composition of glycyrrhizin or its salts and the preparation method thereof |
| 07/17/2008 | WO2007101264A3 Method for treating endothelial and epithelial cell disorders by administering high molecular weight peg-like compounds |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171788 N-(diaminomethylene)-9H-fluorene-2-carboxamide derivatives; dual antagonist for 5-HT2B and 5-HT7 receptors having selective binding affinities for 5-HT2B and 5-HT7 receptors; side effect reduction, nontoxic |
| 07/17/2008 | US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/17/2008 | US20080171737 Cyclic sulfonamide derivatives and methods of their use |
| 07/17/2008 | US20080171702 Novel gene and uses therefor |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080171106 Exposing probiotic to a gastric juice; providing a model of a pet small intestine;introducing the probiotic and a pathogen into the model;measuring anti-pathogenic metabolite produced by probiotic; andusing the identified probiotic to produce a pet food |
| 07/17/2008 | US20080171089 Stable anti-nausea oral spray formulations and methods |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171046 Novel proteins and nucleic acids encoding same |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | US20080171014 Interleukin-13 binding proteins |
| 07/16/2008 | EP1944301A1 Novel benzoxathiin derivative |
| 07/16/2008 | EP1944298A1 Quinazoline derivative and pharmaceutical |
| 07/16/2008 | EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 07/16/2008 | EP1944290A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 07/16/2008 | EP1944033A2 Use of pectin hydrolysis products |
| 07/16/2008 | EP1942914A2 Use of an activated zeolite as a pharmaceutical agent for reducing poisonous substances |
| 07/16/2008 | EP1942894A1 Preparation for the treatment of diarrhoea |
| 07/16/2008 | EP1942892A1 Solid dispersions of opioid antagonists |
| 07/16/2008 | EP1660093B1 Ammonium salts of ornithine derivatives for treating inflammatory diseases |
| 07/16/2008 | EP1506205B1 Novel azacyclic ethynyl derivatives |
| 07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
| 07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | EP1390372B1 1-oxa-3,9-diaza-spiro'5,5]undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor |
| 07/16/2008 | EP1313440B1 Dental products comprising bone growth enhancing peptide |
| 07/16/2008 | EP1294383B1 Oral compositions comprising antimicrobial agents for the prevention of systemic diseases |
| 07/16/2008 | EP1294367B1 Oral compositions comprising host-response modulating agent |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | EP1178789B1 Method of treating eating disorders |
| 07/16/2008 | CN101222931A Cynara scolymus extracts, the use thereof and formulations containing them |
| 07/16/2008 | CN101222921A Use of mGluR5 (esp. AFQ056) in gi (esp. gerd) |
| 07/16/2008 | CN101220373A Recombined viral vectors and uses thereof |
| 07/16/2008 | CN101220071A Stable 6-methoxy-2í»,3í»-dideoxy guanine nucleoside, method for preparing the same and medicament composition containing the same |
| 07/16/2008 | CN101220067A Diphosphate salt of a 4 -substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 07/16/2008 | CN101220028A Urea substituted imidazopyridines |
| 07/16/2008 | CN101219191A Medicament for preventing and controlling atony of proventriculus of ruminant |
| 07/16/2008 | CN101219188A Anti-inflammation antalgica liquid |
| 07/16/2008 | CN101219181A Method for preparing medicine for for treating children's anorexia |
| 07/16/2008 | CN101219180A Health care wine and its processing method |
| 07/16/2008 | CN101219170A Chinese medicine composition for treating alcoholic liver |
| 07/16/2008 | CN101219167A Method for preparing capsule for expelling stone |
| 07/16/2008 | CN101219165A Unfermented gel fraction from psyllium seed husks |
| 07/16/2008 | CN101219163A Method for preparing confinement water |
| 07/16/2008 | CN101219150A Rapidly effectual aluminum magnesium carbonate preparation and technique of preparing the same |
| 07/16/2008 | CN101219146A Compound levamisol (hydrochlorate) dipyridamole injection preparation |
| 07/16/2008 | CN101219138A Treatment of esophageal high grade dysplasia using photodynamic therapy |
| 07/16/2008 | CN101219137A Treatment of esophageal high grade dysplasia using photodynamic therapy |
| 07/16/2008 | CN101219133A Levorotation carnitine pellet and method for preparing the same |
| 07/16/2008 | CN101218968A Production method for teel ginger |
| 07/16/2008 | CN101218954A Chinese cabbage ice cream |
| 07/16/2008 | CN101218946A Pearl milky tea preparation for enlivening spleen and nourishing stomach with dietary cure |
| 07/16/2008 | CN100402643C 感染性克隆 Infectious clone |
| 07/16/2008 | CN100402545C Methods and compositions for treating hepatitis c virus |
| 07/16/2008 | CN100402528C Urea substituted imidazopyridines |
| 07/16/2008 | CN100402521C 4-imidazolin-2-one compounds |
| 07/16/2008 | CN100402496C Compounds useful as matrix metalloprotease inhibitors |
| 07/16/2008 | CN100402494C Myoinositol sulfate aluminium , its preparation method and oral compositions and uses |
| 07/16/2008 | CN100402090C Mucosa-immune composite adjuvant |
| 07/16/2008 | CN100402086C Slow released nano microsphere gel of alkaline fibroblast growth factor and polylactic acid and its preparing method |
| 07/16/2008 | CN100402085C Production of high-concentration thymic peptide solution and large-specification thymic peptide preparation |
| 07/16/2008 | CN100402082C Topically applied medicine for treating chronic entiritis |
| 07/16/2008 | CN100402078C Medicinal pills for clearing liver heat, dispelling toxic materials and promoting diuresis |
| 07/16/2008 | CN100402076C Medicine for treating gastropathy and its preparation method |
| 07/16/2008 | CN100402064C Liver-protecting sobering-up capsule and method for preparing the same by utilizing grape peel |
| 07/16/2008 | CN100402062C Hepatitis treating Chinese medicine preparation and its preparation process |
| 07/16/2008 | CN100402056C Medicine for curing toothache |
| 07/16/2008 | CN100402042C Composition and method for augmenting kidney function |
| 07/16/2008 | CN100402038C Use of ginseng saponin C-K in preparing medicine for treating or preventing liver fibrosis |
| 07/16/2008 | CN100402025C Modified release pharmaceutical formulation |
| 07/16/2008 | CN100402023C Legalon soft capsule and its preparing method |
| 07/15/2008 | US7399878 Pharmaceutical compounds |
| 07/15/2008 | US7399829 Variants of RANKL protein |
| 07/15/2008 | US7399821 Alkylated poly(allylamine) polymers and methods of use |
| 07/15/2008 | US7399779 3,6-disubstituted azabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonists |
| 07/15/2008 | US7399774 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 07/15/2008 | US7399772 Substituted benzimidazole dosage forms and method of using same |
| 07/15/2008 | US7399759 1, 3-benzothiazinone derivatives and use thereof |
| 07/15/2008 | US7399756 Organo-phosphorous compounds for activating gamma/delta T cells |
| 07/15/2008 | US7399605 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide |
| 07/15/2008 | US7399492 Composition and method for issue repair and regeneration |
| 07/15/2008 | US7399485 Rapidly Disintegrable solid preparation |